IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 3,510.00
-100.00 (-2.77%)
Aug 12, 2026, 1:45 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 50.6 billion as of August 11, 2026. Its market cap has decreased by -53.12% in one year.
Market Cap
50.60B
Enterprise Value
31.64B
Revenue
5.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,510.00
ChartMarket Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 50.60B, a decrease of -89.95%. That is a compound annual growth rate of -62.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 50.60B | -63.50% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vaxcell-Bio Therapeutics | 96.98B |
| MedPacto | 94.94B |
| iNtRON Biotechnology | 80.78B |
| Prestige BioPharma | 79.33B |
| CG Invites | 76.43B |
| Amicogen | 72.14B |
| ENCell | 68.05B |
| ORIENT BIO | 63.14B |